-
Review
January 5, 2024
- Comprehensive approach to controlling chronic hepatitis B in China
- Shan Shan, Xinyan Zhao, Jidong Jia
- Clin Mol Hepatol. 2024;30(2):135-143.
Review
January 5, 2024
Original Article
December 29, 2023
Original Article
January 8, 2024
Original Article
January 8, 2024
Original Article
January 24, 2024
Original Article
January 26, 2024
Original Article
January 26, 2024
This archive contains links to the full-text of all issues of Clin Mol Hepatol.
![]() |
First decision
09 Days
Publication after acceptance
03 Days
*Last 12 months
Viewed By 6733 |
Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment |
Viewed By 5782 |
MAFLD: How is it different from NAFLD? |
Viewed By 5535 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Viewed By 4846 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Viewed By 4471 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma |
Cited By 169 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Cited By 108 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma |
Cited By 108 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Cited By 80 |
MAFLD: How is it different from NAFLD? |
Cited By 77 |
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach |